BriaCell Therapeutics Corp. (BCTX) Receivables - Other (2022 - 2025)
BriaCell Therapeutics (BCTX) posted Receivables - Other of $119009.0 for Q3 2025, down 74.86% sequentially from $473330.0 in Q3 2024, and down 74.86% YoY from $473330.0 in Q3 2024.
BriaCell Therapeutics Corp. (BCTX) Receivables - Other (2022 - 2025) Analysis & Trends
BriaCell Therapeutics has reported Receivables - Other for 4 years, with the latest figure at $119009.0 in Q3 2025.
- Quarterly Receivables - Other fell 74.86% year-over-year to $119009.0 in Q3 2025, while the trailing twelve-month figure through Jul 2025 was $119009.0 (down 74.86% YoY) and the FY2025 annual result came in at $119009.0, down 74.86% from the prior year.
- Receivables - Other eased to $119009.0 in Q3 2025 per BCTX's latest filing, from $473330.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $473330.0 in Q3 2024 and troughed at $40753.0 in Q3 2023.
- A 4-year average of $177162.5 and a median of $97283.5 in 2022 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 1061.46% in 2024, then plunged 74.86% in 2025.
- Over 4 years, Receivables - Other stood at $75558.0 in 2022, then sank by 46.06% to $40753.0 in 2023, then soared by 1061.46% to $473330.0 in 2024, then slumped by 74.86% to $119009.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $119009.0, $473330.0, and $40753.0 for Q3 2025, Q3 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 119,009.00 |
| Jul 31, 2025 | 119,009.00 |
| Jul 31, 2024 | 473,330.00 |
| Jul 31, 2024 | 473,330.00 |
| Jul 31, 2023 | 40,753.00 |
| Jul 31, 2023 | 40,753.00 |
| Jul 31, 2022 | 75,558.00 |
| Jul 31, 2022 | 75,558.00 |